Tang Mitosis/Apoptosis ver. II - Dataset (ID:20003)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | Assay compound conc (uM) | Day | Image | Cell count | Interphase count | Apoptotic count | Dead count | Mitotic count | % Interphase | % Apoptotic | % Mitotic | Recorded Plate | Recorded Well | Control Type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tozasertib | PE/CA-PJ15 | 3.7 | 3 | | 807 | 752 | 38 | 1 | 16 | 93.19 | 4.83 | 1.98 | 6 | E15 | |
GSK1070916 | PE/CA-PJ15 | 3.7 | 1 | | 637 | 577 | 22 | 2 | 36 | 90.58 | 3.77 | 5.65 | 6 | E16 | |
GSK1070916 | PE/CA-PJ15 | 3.7 | 2 | | 876 | 822 | 23 | 6 | 25 | 93.84 | 3.31 | 2.85 | 6 | E16 | |
GSK1070916 | PE/CA-PJ15 | 3.7 | 3 | | 777 | 689 | 71 | 6 | 11 | 88.67 | 9.91 | 1.42 | 6 | E16 | |
Tozasertib | PE/CA-PJ15 | 0.0051 | 1 | | 939 | 895 | 16 | 2 | 26 | 95.31 | 1.92 | 2.77 | 6 | E17 | |
Tozasertib | PE/CA-PJ15 | 0.0051 | 2 | | 2049 | 1951 | 39 | 0 | 59 | 95.22 | 1.90 | 2.88 | 6 | E17 | |
Tozasertib | PE/CA-PJ15 | 0.0051 | 3 | | 3137 | 2993 | 47 | 0 | 97 | 95.41 | 1.50 | 3.09 | 6 | E17 | |
GSK1070916 | PE/CA-PJ15 | 3.7 | 1 | | 690 | 623 | 27 | 3 | 37 | 90.29 | 4.35 | 5.36 | 6 | E18 | |
GSK1070916 | PE/CA-PJ15 | 3.7 | 2 | | 797 | 729 | 37 | 5 | 26 | 91.47 | 5.27 | 3.26 | 6 | E18 | |
GSK1070916 | PE/CA-PJ15 | 3.7 | 3 | | 811 | 717 | 81 | 2 | 11 | 88.41 | 10.23 | 1.36 | 6 | E18 | |
Tozasertib | PE/CA-PJ15 | 0.0051 | 1 | | 945 | 895 | 17 | 2 | 31 | 94.71 | 2.01 | 3.28 | 6 | E19 | |
Tozasertib | PE/CA-PJ15 | 0.0051 | 2 | | 2083 | 1971 | 28 | 28 | 56 | 94.62 | 2.69 | 2.69 | 6 | E19 | |
Tozasertib | PE/CA-PJ15 | 0.0051 | 3 | | 3336 | 3185 | 39 | 0 | 112 | 95.47 | 1.17 | 3.36 | 6 | E19 | |
GSK1070916 | PE/CA-PJ15 | 0.0051 | 1 | | 982 | 903 | 28 | 21 | 30 | 91.96 | 4.99 | 3.06 | 6 | E20 | |
GSK1070916 | PE/CA-PJ15 | 0.0051 | 2 | | 2105 | 2010 | 36 | 0 | 59 | 95.49 | 1.71 | 2.80 | 6 | E20 | |
GSK1070916 | PE/CA-PJ15 | 0.0051 | 3 | | 3191 | 3065 | 33 | 0 | 93 | 96.05 | 1.03 | 2.91 | 6 | E20 | |
PE/CA-PJ15 | 1 | | 932 | 874 | 21 | 3 | 34 | 93.78 | 2.58 | 3.65 | 6 | E21 | N | ||
PE/CA-PJ15 | 2 | | 2107 | 2023 | 38 | 0 | 46 | 96.01 | 1.80 | 2.18 | 6 | E21 | N | ||
PE/CA-PJ15 | 3 | | 3237 | 3101 | 47 | 0 | 89 | 95.80 | 1.45 | 2.75 | 6 | E21 | N | ||
GSK1070916 | PE/CA-PJ15 | 0.0051 | 1 | | 928 | 867 | 21 | 2 | 38 | 93.43 | 2.48 | 4.09 | 6 | E22 | |
GSK1070916 | PE/CA-PJ15 | 0.0051 | 2 | | 2264 | 2152 | 39 | 0 | 73 | 95.05 | 1.72 | 3.22 | 6 | E22 | |
GSK1070916 | PE/CA-PJ15 | 0.0051 | 3 | | 3214 | 3076 | 42 | 0 | 96 | 95.71 | 1.31 | 2.99 | 6 | E22 | |
Barasertib | PE/CA-PJ15 | 3.7 | 1 | | 747 | 677 | 32 | 3 | 35 | 90.63 | 4.69 | 4.69 | 6 | F03 | |
Barasertib | PE/CA-PJ15 | 3.7 | 2 | | 996 | 919 | 52 | 5 | 20 | 92.27 | 5.72 | 2.01 | 6 | F03 | |
Barasertib | PE/CA-PJ15 | 3.7 | 3 | | 686 | 613 | 63 | 4 | 6 | 89.36 | 9.77 | 0.87 | 6 | F03 |